| | |
| Clinical data | |
|---|---|
| Other names | 6-Br-MDMA; 6Br-MDMA; 6-Bromo-3,4-methylenedioxy-N-methylamphetamine; 2-Br-4,5-MDMA |
| Drug class | Psychoactive drug; Serotonin reuptake inhibitor |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| Chemical and physical data | |
| Formula | C11H14BrNO2 |
| Molar mass | 272.142 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
6-Bromo-MDMA, also known as 6-bromo-3,4-methylenedioxy-N-methylamphetamine or as 2-bromo-4,5-methylenedioxymethamphetamine (2-Br-4,5-MDMA), is a psychoactive drug of the phenethylamine, amphetamine, and MDxx families related to MDMA. [1] [2] [3] It does not appear to be a serotonin releasing agent like MDMA, but instead to be a serotonin reuptake inhibitor like citalopram, and with much greater serotonin transporter (SERT) affinity than MDMA. [1] Relatedly, 6-bromo-MDMA lacked key MDMA-like behavioral effects in rodents, including hyperlocomotion, enhanced active avoidance conditioning, and increased social interaction. [1] The drug was encountered as a novel designer drug in Europe in 2014. [2] [3]
{{cite journal}}: CS1 maint: unflagged free DOI (link)| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||
| | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |